Default company panoramic image
1a0e039a 0c2b 460d 90d4 856958094324

Hilltop BioSciences

Hilltop Bio develops exosome-based cell signaling technology to reduce inflammation and provide the necessary components to restore the body's immune balance.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded September 2018
  • Employees 6
  • Incorporation Type C-corp
  • Website

Company Summary

Hilltop is changing the way we treat our animals, with easy-to-use therapies that help the body heal itself after injury or inflammatory disease. Our therapies are room temperature, making them one of the first regenerative therapies that our vets can keep on the shelf as they would a pharmaceutical product.

We have hit all of our milestones and 96% of vets repeat purchase within 2 months of trying the products. Currently, Hilltop is B2B.


  • F4c79348 dd1e 4b09 8f86 57b52dded67e
    VP Sales and Distribution

    20 years experience in veterinary sales, bringing new products to market and leading large sales teams

  • C223e817 6782 4dd8 8004 2d7044c9c83e
    Chief Veterinary Officer

    Dr. Dutton is an equine sports medicine veterinarian with 20+ years experience as a practice owner and treating vet. He has researched and used a variety of regenerative therapies in many different indications and brings his experiences and expertise to Hilltop Bio.